Global Insulin Glargine Market Growth 2025-2031

December 2024 | 75 pages | ID: GFA6B7281B3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Insulin Glargine market size is predicted to grow from US$ 7093 million in 2025 to US$ 9053 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a 'peakless' profile (according to the insulin glargine package insert).

Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.

USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.

In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.

LP Information, Inc. (LPI) ' newest research report, the “Insulin Glargine Industry Forecast” looks at past sales and reviews total world Insulin Glargine sales in 2024, providing a comprehensive analysis by region and market sector of projected Insulin Glargine sales for 2025 through 2031. With Insulin Glargine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insulin Glargine industry.

This Insight Report provides a comprehensive analysis of the global Insulin Glargine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Insulin Glargine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insulin Glargine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insulin Glargine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insulin Glargine.

This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Glargine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Single Dose Vial
• Pre-filled Syringe

Segmentation by Application:

• Treat Type2 Diabetes
• Treat Type1 Diabetes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi-Aventis
• Ganlee
• Biocon

Key Questions Addressed in this Report

What is the 10-year outlook for the global Insulin Glargine market?

What factors are driving Insulin Glargine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Insulin Glargine market opportunities vary by end market size?

How does Insulin Glargine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Insulin Glargine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Insulin Glargine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Insulin Glargine by Country/Region, 2020, 2024 & 2031
2.2 Insulin Glargine Segment by Type
  2.2.1 Single Dose Vial
  2.2.2 Pre-filled Syringe
2.3 Insulin Glargine Sales by Type
  2.3.1 Global Insulin Glargine Sales Market Share by Type (2020-2025)
  2.3.2 Global Insulin Glargine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Insulin Glargine Sale Price by Type (2020-2025)
2.4 Insulin Glargine Segment by Application
  2.4.1 Treat Type2 Diabetes
  2.4.2 Treat Type1 Diabetes
2.5 Insulin Glargine Sales by Application
  2.5.1 Global Insulin Glargine Sale Market Share by Application (2020-2025)
  2.5.2 Global Insulin Glargine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Insulin Glargine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Insulin Glargine Breakdown Data by Company
  3.1.1 Global Insulin Glargine Annual Sales by Company (2020-2025)
  3.1.2 Global Insulin Glargine Sales Market Share by Company (2020-2025)
3.2 Global Insulin Glargine Annual Revenue by Company (2020-2025)
  3.2.1 Global Insulin Glargine Revenue by Company (2020-2025)
  3.2.2 Global Insulin Glargine Revenue Market Share by Company (2020-2025)
3.3 Global Insulin Glargine Sale Price by Company
3.4 Key Manufacturers Insulin Glargine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Insulin Glargine Product Location Distribution
  3.4.2 Players Insulin Glargine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INSULIN GLARGINE BY GEOGRAPHIC REGION

4.1 World Historic Insulin Glargine Market Size by Geographic Region (2020-2025)
  4.1.1 Global Insulin Glargine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Insulin Glargine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Insulin Glargine Market Size by Country/Region (2020-2025)
  4.2.1 Global Insulin Glargine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Insulin Glargine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Insulin Glargine Sales Growth
4.4 APAC Insulin Glargine Sales Growth
4.5 Europe Insulin Glargine Sales Growth
4.6 Middle East & Africa Insulin Glargine Sales Growth

5 AMERICAS

5.1 Americas Insulin Glargine Sales by Country
  5.1.1 Americas Insulin Glargine Sales by Country (2020-2025)
  5.1.2 Americas Insulin Glargine Revenue by Country (2020-2025)
5.2 Americas Insulin Glargine Sales by Type (2020-2025)
5.3 Americas Insulin Glargine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Insulin Glargine Sales by Region
  6.1.1 APAC Insulin Glargine Sales by Region (2020-2025)
  6.1.2 APAC Insulin Glargine Revenue by Region (2020-2025)
6.2 APAC Insulin Glargine Sales by Type (2020-2025)
6.3 APAC Insulin Glargine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Insulin Glargine by Country
  7.1.1 Europe Insulin Glargine Sales by Country (2020-2025)
  7.1.2 Europe Insulin Glargine Revenue by Country (2020-2025)
7.2 Europe Insulin Glargine Sales by Type (2020-2025)
7.3 Europe Insulin Glargine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Insulin Glargine by Country
  8.1.1 Middle East & Africa Insulin Glargine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Insulin Glargine Revenue by Country (2020-2025)
8.2 Middle East & Africa Insulin Glargine Sales by Type (2020-2025)
8.3 Middle East & Africa Insulin Glargine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin Glargine
10.3 Manufacturing Process Analysis of Insulin Glargine
10.4 Industry Chain Structure of Insulin Glargine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Insulin Glargine Distributors
11.3 Insulin Glargine Customer

12 WORLD FORECAST REVIEW FOR INSULIN GLARGINE BY GEOGRAPHIC REGION

12.1 Global Insulin Glargine Market Size Forecast by Region
  12.1.1 Global Insulin Glargine Forecast by Region (2026-2031)
  12.1.2 Global Insulin Glargine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Insulin Glargine Forecast by Type (2026-2031)
12.7 Global Insulin Glargine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi-Aventis
  13.1.1 Sanofi-Aventis Company Information
  13.1.2 Sanofi-Aventis Insulin Glargine Product Portfolios and Specifications
  13.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi-Aventis Main Business Overview
  13.1.5 Sanofi-Aventis Latest Developments
13.2 Ganlee
  13.2.1 Ganlee Company Information
  13.2.2 Ganlee Insulin Glargine Product Portfolios and Specifications
  13.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Ganlee Main Business Overview
  13.2.5 Ganlee Latest Developments
13.3 Biocon
  13.3.1 Biocon Company Information
  13.3.2 Biocon Insulin Glargine Product Portfolios and Specifications
  13.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Biocon Main Business Overview
  13.3.5 Biocon Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Insulin Glargine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Insulin Glargine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Single Dose Vial
Table 4. Major Players of Pre-filled Syringe
Table 5. Global Insulin Glargine Sales byType (2020-2025) & (M mL)
Table 6. Global Insulin Glargine Sales Market Share byType (2020-2025)
Table 7. Global Insulin Glargine Revenue byType (2020-2025) & ($ million)
Table 8. Global Insulin Glargine Revenue Market Share byType (2020-2025)
Table 9. Global Insulin Glargine Sale Price byType (2020-2025) & (USD/mL)
Table 10. Global Insulin Glargine Sale by Application (2020-2025) & (M mL)
Table 11. Global Insulin Glargine Sale Market Share by Application (2020-2025)
Table 12. Global Insulin Glargine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Insulin Glargine Revenue Market Share by Application (2020-2025)
Table 14. Global Insulin Glargine Sale Price by Application (2020-2025) & (USD/mL)
Table 15. Global Insulin Glargine Sales by Company (2020-2025) & (M mL)
Table 16. Global Insulin Glargine Sales Market Share by Company (2020-2025)
Table 17. Global Insulin Glargine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Insulin Glargine Revenue Market Share by Company (2020-2025)
Table 19. Global Insulin Glargine Sale Price by Company (2020-2025) & (USD/mL)
Table 20. Key Manufacturers Insulin Glargine Producing Area Distribution and Sales Area
Table 21. Players Insulin Glargine Products Offered
Table 22. Insulin Glargine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Insulin Glargine Sales by Geographic Region (2020-2025) & (M mL)
Table 26. Global Insulin Glargine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Insulin Glargine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Insulin Glargine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Insulin Glargine Sales by Country/Region (2020-2025) & (M mL)
Table 30. Global Insulin Glargine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Insulin Glargine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Insulin Glargine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Insulin Glargine Sales by Country (2020-2025) & (M mL)
Table 34. Americas Insulin Glargine Sales Market Share by Country (2020-2025)
Table 35. Americas Insulin Glargine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Insulin Glargine Sales byType (2020-2025) & (M mL)
Table 37. Americas Insulin Glargine Sales by Application (2020-2025) & (M mL)
Table 38. APAC Insulin Glargine Sales by Region (2020-2025) & (M mL)
Table 39. APAC Insulin Glargine Sales Market Share by Region (2020-2025)
Table 40. APAC Insulin Glargine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Insulin Glargine Sales byType (2020-2025) & (M mL)
Table 42. APAC Insulin Glargine Sales by Application (2020-2025) & (M mL)
Table 43. Europe Insulin Glargine Sales by Country (2020-2025) & (M mL)
Table 44. Europe Insulin Glargine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Insulin Glargine Sales byType (2020-2025) & (M mL)
Table 46. Europe Insulin Glargine Sales by Application (2020-2025) & (M mL)
Table 47. Middle East & Africa Insulin Glargine Sales by Country (2020-2025) & (M mL)
Table 48. Middle East & Africa Insulin Glargine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Insulin Glargine Sales byType (2020-2025) & (M mL)
Table 50. Middle East & Africa Insulin Glargine Sales by Application (2020-2025) & (M mL)
Table 51. Key Market Drivers & Growth Opportunities of Insulin Glargine
Table 52. Key Market Challenges & Risks of Insulin Glargine
Table 53. Key IndustryTrends of Insulin Glargine
Table 54. Insulin Glargine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Insulin Glargine Distributors List
Table 57. Insulin Glargine Customer List
Table 58. Global Insulin Glargine SalesForecast by Region (2026-2031) & (M mL)
Table 59. Global Insulin Glargine RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Insulin Glargine SalesForecast by Country (2026-2031) & (M mL)
Table 61. Americas Insulin Glargine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Insulin Glargine SalesForecast by Region (2026-2031) & (M mL)
Table 63. APAC Insulin Glargine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Insulin Glargine SalesForecast by Country (2026-2031) & (M mL)
Table 65. Europe Insulin Glargine RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Insulin Glargine SalesForecast by Country (2026-2031) & (M mL)
Table 67. Middle East & Africa Insulin Glargine RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Insulin Glargine SalesForecast byType (2026-2031) & (M mL)
Table 69. Global Insulin Glargine RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Insulin Glargine SalesForecast by Application (2026-2031) & (M mL)
Table 71. Global Insulin Glargine RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Sanofi-Aventis Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi-Aventis Insulin Glargine Product Portfolios and Specifications
Table 74. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2020-2025)
Table 75. Sanofi-Aventis Main Business
Table 76. Sanofi-Aventis Latest Developments
Table 77. Ganlee Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors
Table 78. Ganlee Insulin Glargine Product Portfolios and Specifications
Table 79. Ganlee Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2020-2025)
Table 80. Ganlee Main Business
Table 81. Ganlee Latest Developments
Table 82. Biocon Basic Information, Insulin Glargine Manufacturing Base, Sales Area and Its Competitors
Table 83. Biocon Insulin Glargine Product Portfolios and Specifications
Table 84. Biocon Insulin Glargine Sales (M mL), Revenue ($ Million), Price (USD/mL) and Gross Margin (2020-2025)
Table 85. Biocon Main Business
Table 86. Biocon Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Insulin Glargine
Figure 2. Insulin Glargine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insulin Glargine Sales Growth Rate 2020-2031 (M mL)
Figure 7. Global Insulin Glargine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Insulin Glargine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Insulin Glargine Sales Market Share by Country/Region (2024)
Figure 10. Insulin Glargine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Single Dose Vial
Figure 12. Product Picture of Pre-filled Syringe
Figure 13. Global Insulin Glargine Sales Market Share byType in 2025
Figure 14. Global Insulin Glargine Revenue Market Share byType (2020-2025)
Figure 15. Insulin Glargine Consumed inTreatType2 Diabetes
Figure 16. Global Insulin Glargine Market:TreatType2 Diabetes (2020-2025) & (M mL)
Figure 17. Insulin Glargine Consumed inTreatType1 Diabetes
Figure 18. Global Insulin Glargine Market:TreatType1 Diabetes (2020-2025) & (M mL)
Figure 19. Global Insulin Glargine Sale Market Share by Application (2024)
Figure 20. Global Insulin Glargine Revenue Market Share by Application in 2025
Figure 21. Insulin Glargine Sales by Company in 2025 (M mL)
Figure 22. Global Insulin Glargine Sales Market Share by Company in 2025
Figure 23. Insulin Glargine Revenue by Company in 2025 ($ millions)
Figure 24. Global Insulin Glargine Revenue Market Share by Company in 2025
Figure 25. Global Insulin Glargine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Insulin Glargine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Insulin Glargine Sales 2020-2025 (M mL)
Figure 28. Americas Insulin Glargine Revenue 2020-2025 ($ millions)
Figure 29. APAC Insulin Glargine Sales 2020-2025 (M mL)
Figure 30. APAC Insulin Glargine Revenue 2020-2025 ($ millions)
Figure 31. Europe Insulin Glargine Sales 2020-2025 (M mL)
Figure 32. Europe Insulin Glargine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Insulin Glargine Sales 2020-2025 (M mL)
Figure 34. Middle East & Africa Insulin Glargine Revenue 2020-2025 ($ millions)
Figure 35. Americas Insulin Glargine Sales Market Share by Country in 2025
Figure 36. Americas Insulin Glargine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Insulin Glargine Sales Market Share byType (2020-2025)
Figure 38. Americas Insulin Glargine Sales Market Share by Application (2020-2025)
Figure 39. United States Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Insulin Glargine Sales Market Share by Region in 2025
Figure 44. APAC Insulin Glargine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Insulin Glargine Sales Market Share byType (2020-2025)
Figure 46. APAC Insulin Glargine Sales Market Share by Application (2020-2025)
Figure 47. China Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Insulin Glargine Sales Market Share by Country in 2025
Figure 55. Europe Insulin Glargine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Insulin Glargine Sales Market Share byType (2020-2025)
Figure 57. Europe Insulin Glargine Sales Market Share by Application (2020-2025)
Figure 58. Germany Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 59.France Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Insulin Glargine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Insulin Glargine Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Insulin Glargine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Insulin Glargine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Insulin Glargine in 2025
Figure 72. Manufacturing Process Analysis of Insulin Glargine
Figure 73. Industry Chain Structure of Insulin Glargine
Figure 74. Channels of Distribution
Figure 75. Global Insulin Glargine Sales MarketForecast by Region (2026-2031)
Figure 76. Global Insulin Glargine Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Insulin Glargine Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Insulin Glargine Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Insulin Glargine Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Insulin Glargine Revenue Market ShareForecast by Application (2026-2031)